Sudden Death Associated With Danon Disease in Women

被引:51
作者
Miani, Daniela [1 ,2 ]
Taylor, Matthew [4 ,5 ]
Mestroni, Luisa [4 ,5 ]
D'Aurizio, Federica [3 ]
Finato, Nicoletta [3 ]
Fanin, Marina [6 ]
Brigido, Silvana [1 ]
Proclemer, Alessandro [1 ]
机构
[1] Univ Hosp S Maria della Misericordia, Dept Cardiothorac Sci, Udine, Italy
[2] Univ Hosp S Maria della Misericordia, IRCAB Fdn, Udine, Italy
[3] Univ Hosp S Maria della Misericordia, Dept Med & Morphol Res, Surg Pathol Sect, Udine, Italy
[4] Univ Colorado Denver, Cardiovasc Inst, Aurora, CO USA
[5] Univ Colorado Denver, Adult Med Genet Program, Aurora, CO USA
[6] Univ Padua, Inst Mol Med, Dept Neurosci & Venetian, Padua, Italy
关键词
HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; MUTATION ANALYSIS; EXPRESSION; MYOPATHY; LGMD2A;
D O I
10.1016/j.amjcard.2011.09.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Danon disease is an X-linked systemic disorder characterized by left ventricular hypertrophy, mental retardation, and skeletal myopathy affecting young men. Electrocardiogram usually displays a Wolff Parkinson White preexcitation pattern. Less has been reported about the phenotype in women, although later-onset cardiac symptoms have been described. The aim of this study was to expand the knowledge of the phenotype of Danon disease in women. We clinically followed and evaluated with echocardiography, cardiac magnetic resonance imaging (cMRI), and genetic testing a family affected by Danon disease in which 2 men and 6 women showed a severe arrhythmogenic phenotype. Affected family members carried a nucleotide substitution at position 294 in exon 3 (c.294 G -> A) that changed a tryptophan residue to a stop codon at position W98X in the lysosome-associated membrane protein 2 (LAMP2) gene. Four women died suddenly (1 aborted) at 37 to 54 years of age. Wolff Parkinson White pattern with atrioventricular block was detected in 2 of 6 women. Four had successful pregnancies without symptoms of heart failure. cMRI showed late gadolinium enhancement areas in a clinically healthy woman who was a mutation carrier. Two patients underwent heart transplantation; histology of explanted hearts demonstrated severe interstitial fibrosis, hypertrophic cardiomyocytes with cytoplasmic vacuoles, and myofibrillar disarray. In conclusion, LAMP2 mutation can cause a severe arrhythmogenic phenotype in women that includes a high risk of sudden death. cMRI may be useful in women harboring LAMP2 mutations to permit early detection of cardiac involvement and guide timely considerations of implantable cardioverter defibrillator therapy. Heart transplantation should be considered at onset of heart failure symptoms owing to rapid progression of the disease. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;109:406-411)
引用
收藏
页码:406 / 411
页数:6
相关论文
共 17 条
[1]   Glycogen storage diseases presenting as hypertrophic cardiomyopathy [J].
Arad, M ;
Maron, BJ ;
Gorham, JM ;
Johnson, WH ;
Saul, JP ;
Perez-Atayde, AR ;
Spirito, P ;
Wright, GB ;
Kanter, RJ ;
Seidman, CE ;
Seidman, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :362-372
[2]   Familial X-linked cardiomyopathy (Danon disease):: diagnostic confirmation by mutation analysis of the LAMP2gene [J].
Balmer, C ;
Ballhausen, D ;
Bosshard, NU ;
Steinmann, B ;
Boltshauser, E ;
Bauersfeld, U ;
Superti-Furga, A .
EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (08) :509-514
[3]   Natural history of Danon disease [J].
Boucek, Dana ;
Jirikowic, Jean ;
Taylor, Matthew .
GENETICS IN MEDICINE, 2011, 13 (06) :563-568
[4]   Danon's disease as a cause of hypertrophic cardiomyopathy:: a systematic survey [J].
Charron, P ;
Villard, E ;
Sébillon, P ;
Laforêt, P ;
Maisonobe, T ;
Duboscq-Bidot, L ;
Romero, N ;
Drouin-Garraud, V ;
Frébourg, T ;
Richard, P ;
Eymard, B ;
Komajda, M .
HEART, 2004, 90 (08) :842-846
[5]   LYSOSOMAL GLYCOGEN-STORAGE DISEASE WITH NORMAL ACID MALTASE [J].
DANON, MJ ;
OH, SJ ;
DIMAURO, S ;
MANALIGOD, JR ;
EASTWOOD, A ;
NAIDU, S ;
SCHLISELFELD, LH .
NEUROLOGY, 1981, 31 (01) :51-57
[6]   Novel LAMP-2 Mutation in a Family With Danon Disease Presenting With Hypertrophic Cardiomyopathy [J].
Dougu, Nobuhiro ;
Joho, Shuji ;
Shan, Lishen ;
Shida, Takuya ;
Matsuki, Akira ;
Uese, Keiichiro ;
Hirono, Keiichi ;
Ichida, Fukiko ;
Tanaka, Kortaro ;
Nishino, Ichizo ;
Inoue, Hiroshi .
CIRCULATION JOURNAL, 2009, 73 (02) :376-380
[7]   Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease [J].
Fanin, M ;
Nascimbeni, AC ;
Fulizio, L ;
Spinazzi, M ;
Melacini, P ;
Angelini, C .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (04) :1309-1320
[8]   Molecular diagnosis in LGMD2A: Mutation analysis or protein testing? [J].
Fanin, M ;
Fulizio, L ;
Nascimbeni, AC ;
Spinazzi, M ;
Piluso, G ;
Ventriglia, VM ;
Ruzza, G ;
Siciliano, G ;
Trevisan, CR ;
Politano, L ;
Nigro, V ;
Angelini, C .
HUMAN MUTATION, 2004, 24 (01) :52-62
[9]   Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression [J].
Fanin, M ;
Nascimbeni, AC ;
Fulizio, L ;
Trevisan, CP ;
Meznaric-Petrusa, M ;
Angelini, C .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1929-1936
[10]   Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy [J].
Maron, Barry J. ;
Roberts, William C. ;
Arad, Michael ;
Haas, Tammy S. ;
Spirito, Paolo ;
Wright, Gregory B. ;
Almquist, Adrian K. ;
Baffa, Jeanne M. ;
Saul, J. Philip ;
Ho, Carolyn Y. ;
Seidman, Jonathan ;
Seidman, Christine E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (12) :1253-1259